` PCLO (Pharmacielo Ltd) vs S&P TSX Composite Index (Canada) Comparison - Alpha Spread

PCLO
vs
S
S&P TSX Composite Index (Canada)

Over the past 12 months, PCLO has underperformed S&P TSX Composite Index (Canada), delivering a return of -65% compared to the S&P TSX Composite Index (Canada)'s +25% growth.

Stocks Performance
PCLO vs S&P TSX Composite Index (Canada)

Loading
PCLO
S&P TSX Composite Index (Canada)
Add Stock
www.alphaspread.com

Performance Gap
PCLO vs S&P TSX Composite Index (Canada)

Performance Gap Between PCLO and GSPTSE
HIDDEN
Show

Performance By Year
PCLO vs S&P TSX Composite Index (Canada)

Loading
PCLO
S&P TSX Composite Index (Canada)
Add Stock

Competitors Performance
Pharmacielo Ltd vs Peers

S&P TSX Composite Index (Canada)
PCLO
LLY
JNJ
ROG
NOVO B
Add Stock

Pharmacielo Ltd
Glance View

Market Cap
8.5m CAD
Industry
Pharmaceuticals

PharmaCielo Ltd. operates as a pharmaceutical company. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-01-30. The Company’s principal subsidiary includes PharmaCielo Colombia Holdings S.A.S. The company produces non-psychoactive and psychoactive extracts. Its psychoactive product line is designed and formulated to meet the needs of the medical industry. Its psychoactive products include THC Distillate and THC:CBD Standardized Oil. Its non-psychoactive products are designed to meet the needs of clients in the medical, nutraceutical and wellness industries. Its non-psychoactive products include Broad-Spectrum Distillate Standardized Oil, CBD Isolate, Broad-Spectrum Distillate, Broad-Spectrum Oil, Water-Soluble CBD, CBD Standardized Oil and Full-Spectrum Standardized Oil.

PCLO Intrinsic Value
HIDDEN
Show
Back to Top